Lara Longpre
Publications by Year
Research Areas
Virus-based gene therapy research, Cancer Research and Treatments, Drug Transport and Resistance Mechanisms, Viral Infectious Diseases and Gene Expression in Insects, Pediatric Hepatobiliary Diseases and Treatments
Most-Cited Works
- → Randomized dose-finding clinical trial of oncolytic immunotherapeutic vaccinia JX-594 in liver cancer(2013)762 cited
- → Randomized trial of intermittent intraputamenal glial cell line-derived neurotrophic factor in Parkinson’s disease(2019)279 cited
- → Extended Treatment with Glial Cell Line-Derived Neurotrophic Factor in Parkinson’s Disease(2019)127 cited
- → Maralixibat in progressive familial intrahepatic cholestasis (MARCH-PFIC): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial(2024)43 cited
- → Phase II trial of Pexa-Vec (pexastimogene devacirepvec; JX-594), an oncolytic and immunotherapeutic vaccinia virus, followed by sorafenib in patients with advanced hepatocellular carcinoma (HCC).(2013)14 cited
- → Phase IIb randomized trial of Pexa-Vec (pexastimogene devacirepvec; JX-594), a targeted oncolytic vaccinia virus, plus best supportive care (BSC) versus BSC alone in patients with advanced hepatocellular carcinoma who have failed sorafenib treatment (TRAVERSE).(2013)9 cited
- → Phase IIb randomized trial of JX-594, a targeted multimechanistic oncolytic vaccinia virus, plus best supportive care (BSC) versus BSC alone in patients with advanced hepatocellular carcinoma who have failed sorafenib treatment (TRAVERSE).(2012)4 cited
- → A phase II trial of JX-594, a targeted multimechanistic oncolytic vaccinia virus, followed by sorafenib in patients with advanced hepatocellular carcinoma (HCC).(2012)3 cited
- → Long-term maintenance of response and improved liver health with maralixibat in patients with progressive familial intrahepatic cholestasis (PFIC): data from the MARCH-ON study(2023)2 cited
- → OC22 Long-term maintenance of response and improved liver heath with maralixibat in patients with progressive familial intrahepatic cholestasis (PFIC): 2-year data from the MARCH-ON study(2025)1 cited